Home » Topics » Regulatory » Patents

Patents
RSS

Disarm Therapeutics discloses SARM1 inhibitors

Nov. 4, 2021

Keaise Medicine patents TRXR inhibitors

Nov. 4, 2021

U.S. researchers patent new meayamycin derivatives

Nov. 3, 2021

GB005 synthesizes BTK inhibitors

Nov. 3, 2021

UCB identifies new IL-17 modulators

Nov. 3, 2021

Foghorn Therapeutics discloses new PROTACs

Nov. 3, 2021

Sanofi patents new YAP1/TEAD interaction inhibitors

Nov. 3, 2021

iTeos Belgium describes new ENT1 inhibitors

Nov. 2, 2021

Cocrystal Pharma presents new antiviral compounds

Nov. 2, 2021

Disarm Therapeutics discloses SARM1 inhibitors

Nov. 2, 2021

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...